Edwin Spaans Person-Info 

( Ich bin Edwin Spaans)

News

(1 - 4 von 12
)

Khondrion presenta los datos del ensayo KHENERGY en Fase II

www.europapress.es
NIJMEGEN, Países Bajos, November 22, PRNewswire Datos de apoyo al desarrollo en fase III de...

Khondrion stellt die Daten der Phase II der KHENERGY-Studie vor |...

www.ots.at
Daten befürworten die Phase III der Entwicklung von KH176 für mitochondriale Erkrankungen

Khondrion Presents Phase II KHENERGY Trial Data

www.finanznachrichten.de
NIJMEGEN, Netherlands, November 22, PRNewswire/ -- Data supporting Phase III development of KH176 in mitochondrial disease Khondrion, a leading...

EEVC Semi-Final HealthCare - International Venture Club

www.iventureclub.com
Edwin Spaans. Director Clinical Development. Kinesis Pharma BV (Netherlands). Life Sciences. Carsten Fredsbo. Medical Device Business Catalyst ...
Dossier exportieren
+1